Co Diagnostics Stock Net Income
| C97 Stock | EUR 5.16 0.00 0.00% |
Fundamental analysis of Co Diagnostics allows traders to better anticipate movements in Co Diagnostics' stock price by examining its financial health and performance throughout various phases of its business cycle.
C97 |
Co Diagnostics Company Net Income Analysis
Co Diagnostics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Co Diagnostics Net Income | 46.22 M |
Most of Co Diagnostics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Co Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Co Diagnostics reported net income of 46.22 M. This is 86.46% lower than that of the Healthcare sector and 73.3% lower than that of the Diagnostics & Research industry. The net income for all Germany stocks is 91.91% higher than that of the company.
C97 Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Co Diagnostics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Co Diagnostics could also be used in its relative valuation, which is a method of valuing Co Diagnostics by comparing valuation metrics of similar companies.Co Diagnostics is currently under evaluation in net income category among its peers.
C97 Fundamentals
| Return On Equity | 76.64 | |||
| Return On Asset | 48.56 | |||
| Profit Margin | 47.97 % | |||
| Operating Margin | 52.10 % | |||
| Current Valuation | 202.65 M | |||
| Shares Outstanding | 28.67 M | |||
| Shares Owned By Insiders | 6.15 % | |||
| Shares Owned By Institutions | 25.41 % | |||
| Price To Earning | 5.79 X | |||
| Price To Book | 3.13 X | |||
| Price To Sales | 2.17 X | |||
| Revenue | 96.35 M | |||
| Gross Profit | 57.96 M | |||
| EBITDA | 50.42 M | |||
| Net Income | 46.22 M | |||
| Cash And Equivalents | 72.38 M | |||
| Cash Per Share | 2.51 X | |||
| Current Ratio | 19.10 X | |||
| Book Value Per Share | 2.34 X | |||
| Cash Flow From Operations | 53.21 M | |||
| Earnings Per Share | 1.26 X | |||
| Number Of Employees | 39 | |||
| Beta | -1.96 | |||
| Market Capitalization | 209.18 M |
About Co Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Co Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Co Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Co Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in C97 Stock
When determining whether Co Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Co Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Co Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Co Diagnostics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Co Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in C97 Stock please use our How to Invest in Co Diagnostics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.